| Failure on Everest: the oxygen equipment of the spring 1952 Swiss expedition. | |
| | |
MedLine Citation:
|
PMID: 12713710 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Swiss expedition to Everest (altitude 8,848 m) in the spring of 1952 very nearly attained the summit with two of the climbers reaching 8,595 m. This would have been the first ascent of Everest. One main reason for failure was the inadequate oxygen equipment which was modified from sets designed for mine rescue using potassium peroxide generators. Oxygen could not be inhaled while the mountaineers were climbing because of the rigid mouthpiece assembly and the high breathing resistance of the equipment. It was argued that breathing oxygen during rest periods would suffice, but this was a fallacy as had been demonstrated by Kellas 30 years before. |
| | |
Authors:
|
John B West |
Publication Detail:
|
Type: Historical Article; Journal Article |
Journal Detail:
|
Title: High altitude medicine & biology Volume: 4 ISSN: 1527-0297 ISO Abbreviation: High Alt. Med. Biol. Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-04-25 Completed Date: 2003-08-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 100901183 Medline TA: High Alt Med Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 39-43 Citation Subset: IM; S |
Affiliation:
|
Department of Medicine, University of California San Diego, La Jolla, CA 92093-0623, USA. jwest@ucsd.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Altitude Altitude Sickness / history, prevention & control Equipment Design Equipment Failure Analysis History, 20th Century Humans Male Mountaineering / history*, physiology Nepal Oxygen / administration & dosage, history* |
| Chemical | |
Reg. No./Substance:
|
7782-44-7/Oxygen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Everest 1953, first ascent: a clinical record.
Next Document: Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a pr...